Digital Content 
NEWS #PharmaBuzz
05 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/latest-clinical-trial-results-support-the-long-term-efficacy-of-two-pharmacological-treatments-in-slowing-progression-of-friedreichs-ataxia-302574027.html
20 Aug 2025
// PRESS RELEASE
https://ir.ptcbio.com/news-releases/news-release-details/ptc-therapeutics-receives-complete-response-letter-vatiquinone
19 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-fda-acceptance-and-priority-review-for-vatiquinone-nda-for-the-treatment-of-children-and-adults-with-friedreichs-ataxia-302379909.html
19 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-vatiquinone-nda-submission-to-fda-for-the-treatment-of-children-and-adults-living-with-friedreich-ataxia-302336134.html
01 Jul 2023
// Katherine Lewin ENDPTS
https://endpts.com/ptc-therapeutics-reports-second-trial-flop-for-vatiquinone-in-mitochondrial-disease-seizures/
29 Jun 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-results-from-mit-e-clinical-trial-of-vatiquinone-for-the-treatment-of-mitochondrial-disease-associated-seizures-301867528.html
Share 